DUBLIN–(BUSINESS WIRE)–The “Pacemakers-Pipeline Insight and Competitive Landscape, 2022” drug pipelines has been added to ResearchAndMarkets.com’s offering.
This “Pacemakers-Pipeline Insight and 2022,” report provides comprehensive insights about 20+ companies and 25+ pipeline devices in Pacemakers pipeline landscape. The Pacemakers market is expected to undergo significant growth in the approaching years owning to an increasing prevalence of cardiovascular disorders around the world. The growing aging population is also a major growth factor for as it is more susceptible to diseases like Cardiac arrest, Heart failure and High blood pressure. Therefore, due to an increase in demand of such devices, huge investment is being made on R&D activities in cardiological sector, which is the major reason for an extensive pipeline in this segment. This report provides a detailed study of the emerging pacemakers along with competitive landscape to help better understand the emerging pacemaker devices.
Pacemakers Devices Competitive Assessment
This segment of the Pacemakers report encloses its detailed analysis of various pipeline devices which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths and estimated approval dates and the latest news and press releases. The report also provides list of major players involved in the pipeline product development.
- Product Type
Pacemakers can be used in two different ways based in types – Implantable and External, both the ways are covered in the report. .
- Product Technology
Pacemakers can be used in two different ways based on technology – Single-chamber pacemaker and Dual-chamber pacemaker, both the ways are covered in the report.
Pacemakers Competitive Benchmarking
This segment of the reports provides analysis of the pipeline report to give a clear understanding of the comparative analysis.
The analysis is based on
- Brand Positioning of Leading companies
- Application
- Industry Collaborations
Pacemakers: Commercialization Activity
This segment of the report provides a detailed list of any commercial activity in the field of pacemakers ranging from collaboration, mergers and acquisition, recent breakthrough among others.
Development Activities
- In February 2020, Researchers at Texas Heart Institute (THI) and UCLA crossed a significant milestone in the development of wirelessly powered, leadless pacemakers. In an article in the Nature Research journal Scientific Reports, the team used their innovative pacing system to reveal the ability to provide synchronized biventricular pacing to a human-sized heart in a preclinical research model. The team is currently working on further miniaturizing the wirelessly powered pacemaker to make it implantable at one or more desired pacing sites on the heart in a minimally invasive manner. This will eliminate the need for intravascular leads and, most importantly, allow for synchronized and leadless pacing across multiple chambers of the heart, which offers the ability to provide patient-specific CRT.
- In January 2020, Medtronic has received Food and Drug Administration (FDA) approval of Micra AV, a pacemaker with atrioventricular (AV) synchrony. Medtronic will begin training field personnel and physicians, and will activate a limited number of implanting centres in the coming weeks, with full launch anticipated later in spring.
Report Highlights
- Extensive coverage of the Pacemakers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Pacemakers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
- The report consists of in depth analysis of pipeline products based on various parameters
Pacemakers Report Insights
- Pacemakers – Pipeline Analysis
- Pacemakers – Unmet Need
- Pacemakers – Market Dynamics
- Pacemakers – Future Perspectives and Conclusion
- Pacemakers – Analyst Views
Key Players
- Medtronic plc
- Boston Scientific Corporation
- Biotronik Se & Co
- LivaNova PLC
- Abbott Laboratories
Key Topics Covered:
1. Key Insights
2. Pacemakers: Snapshot
3. Pacemakers
4. Pacemakers Profiles: Competitive Assessment
5. Pacemakers: Comparative Benchmarking: By Company
6. Pacemakers – Commercialization Activity
7. Pacemakers: Regulatory
8. Pacemakers: Reimbursement
9. Analytical Perspective
10. Conclusion
11. Appendix
12. Bibliography
13. Publisher Capabilities
14. Disclaimer
15. About the Publisher
For more information about this drug pipelines report visit https://www.researchandmarkets.com/r/wyme0d
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900